EP0828751A4 - Human neuropeptide receptor - Google Patents

Human neuropeptide receptor

Info

Publication number
EP0828751A4
EP0828751A4 EP95918991A EP95918991A EP0828751A4 EP 0828751 A4 EP0828751 A4 EP 0828751A4 EP 95918991 A EP95918991 A EP 95918991A EP 95918991 A EP95918991 A EP 95918991A EP 0828751 A4 EP0828751 A4 EP 0828751A4
Authority
EP
European Patent Office
Prior art keywords
neuropeptide receptor
human neuropeptide
human
receptor
neuropeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95918991A
Other languages
German (de)
French (fr)
Other versions
EP0828751A1 (en
Inventor
Daniel R Soppet
Yi Li
Craig A Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP0828751A1 publication Critical patent/EP0828751A1/en
Publication of EP0828751A4 publication Critical patent/EP0828751A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
EP95918991A 1995-05-05 1995-05-05 Human neuropeptide receptor Withdrawn EP0828751A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002220036A CA2220036A1 (en) 1995-05-05 1995-05-05 Human neuropeptide receptor
PCT/US1995/005616 WO1996034877A1 (en) 1995-05-05 1995-05-05 Human neuropeptide receptor

Publications (2)

Publication Number Publication Date
EP0828751A1 EP0828751A1 (en) 1998-03-18
EP0828751A4 true EP0828751A4 (en) 1999-01-20

Family

ID=25679790

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95918991A Withdrawn EP0828751A4 (en) 1995-05-05 1995-05-05 Human neuropeptide receptor

Country Status (3)

Country Link
EP (1) EP0828751A4 (en)
CA (1) CA2220036A1 (en)
WO (1) WO1996034877A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410701B1 (en) 1995-05-05 2002-06-25 Human Genome Sciences, Inc. Human neuropeptide receptor
US20030022277A1 (en) * 1995-05-05 2003-01-30 Daniel R. Soppet Human neuropeptide receptor
US6309854B1 (en) * 1996-12-17 2001-10-30 Smithkline Beecham Corporation Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72
US6001963A (en) * 1996-12-17 1999-12-14 Smithkline Beecham Corporation Ligands of the neuropeptide receptor HFGAN72
CA2287397A1 (en) * 1997-04-24 1998-10-29 Merck Sharp & Dohme Limited Use of an nk-1 receptor antagonist and an ssri for treating obesity
US5935814A (en) * 1997-04-30 1999-08-10 Smithkline Beecham Corporation Polynucleotides encoding HFGAN72Y receptor
US6020157A (en) * 1997-04-30 2000-02-01 Smithkline Beecham Corporation Polynucleotides encoding HFGAN72X receptor
CA2233584A1 (en) * 1997-06-11 1998-12-11 Smithkline Beecham Corporation 7tm receptor hlwar77
US6166193A (en) * 1997-07-25 2000-12-26 Board Of Regents, University Of Texas System Polynucleotides encoding MY1 receptor
WO1999030670A2 (en) * 1997-12-15 1999-06-24 Smithkline Beecham Plc Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
AUPP438598A0 (en) * 1998-06-29 1998-07-23 Garvan Institute Of Medical Research NPY-Y7 receptor gene
WO2000047284A2 (en) * 1999-02-12 2000-08-17 Smithkline Beecham P.L.C. Novel use of orexin receptor antagonists
US6319710B1 (en) 1999-08-23 2001-11-20 Decode Genetics Ehf. Human narcolepsy gene
US6410712B1 (en) * 1999-10-25 2002-06-25 Decode Genetics Ehf. Human narcolepsy gene
ES2263647T3 (en) * 2000-08-25 2006-12-16 Phase One Pharma Oy Ltd. METHOD TO REDUCE OVERPRODUCTION INDUCED BY NEUROPEPTIDE STRESS AND IN AN INDIVIDUAL.
AU2002253361B2 (en) 2001-05-05 2006-08-17 Smithkline Beecham P.L.C. N-aroyl cyclic amines
US8093255B2 (en) 2008-10-09 2012-01-10 Glaxo Group Limited Imidazo[1,2-A]pyrimidines as orexin receptor antagonists
US8129384B2 (en) 2008-10-09 2012-03-06 Glaxo Group Limited Imidazo[1,2-a]pyrazines as orexin receptor antagonists
GB0823467D0 (en) 2008-12-23 2009-01-28 Glaxo Group Ltd Novel Compounds
JP2012524760A (en) 2009-04-24 2012-10-18 グラクソ グループ リミテッド 3-Azabicyclo [4.1.0] heptane used as an orexin antagonist
WO2011023585A1 (en) 2009-08-24 2011-03-03 Glaxo Group Limited Piperidine derivatives used as orexin antagonists
JP2013502447A (en) 2009-08-24 2013-01-24 グラクソ グループ リミテッド 5-Methyl-piperidine derivatives as orexin receptor antagonists for the treatment of sleep disorders
EP2626350B1 (en) 2010-09-22 2015-04-15 Eisai R&D Management Co., Ltd. Cyclopropane compound
WO2012089607A1 (en) 2010-12-28 2012-07-05 Glaxo Group Limited Novel compounds with a 3a-azabicyclo [4.1.0] heptane core acting on orexin receptors
WO2012089606A1 (en) 2010-12-28 2012-07-05 Glaxo Group Limited Azabicyclo [4.1.0] hept - 4 - yl derivatives as human orexin receptor antagonists
WO2016021539A1 (en) 2014-08-06 2016-02-11 エーザイ・アール・アンド・ディー・マネジメント株式会社 Method for producing pyrimidin-1-ol compound, and intermediate thereof
SG11201703064WA (en) 2014-10-23 2017-05-30 Eisai R&D Man Co Ltd Compositions and methods for treating insomnia
EP3993801A4 (en) 2019-09-13 2023-07-19 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating insomnia
KR20220119065A (en) 2019-12-20 2022-08-26 에자이 알앤드디 매니지먼트 가부시키가이샤 Uses of Lemborexant for the Treatment of Insomnia
AU2021308053A1 (en) 2020-07-17 2023-02-02 Eisai R&D Management Co., Ltd. Substituted piperidine compound and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005302A1 (en) * 1994-08-11 1996-02-22 Takeda Chemical Industries, Ltd. G protein coupled receptor protein, production, and use thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005302A1 (en) * 1994-08-11 1996-02-22 Takeda Chemical Industries, Ltd. G protein coupled receptor protein, production, and use thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
H.HERZOG ET AL.: "Genomic Organization, Localization, and Allelic Differences in the Gene for the Human Neuropeptide Y Y1 Receptor", J.BIOL.CHEM., vol. 268, no. 9, 1993, pages 6703 - 7, XP002083378 *
See also references of WO9634877A1 *

Also Published As

Publication number Publication date
WO1996034877A1 (en) 1996-11-07
CA2220036A1 (en) 1996-11-07
EP0828751A1 (en) 1998-03-18

Similar Documents

Publication Publication Date Title
EP0828751A4 (en) Human neuropeptide receptor
GB9505491D0 (en) Therapeutic agents
GB9513118D0 (en) Therapeutic agents
GB9513121D0 (en) Therapeutic agents
GB9513117D0 (en) Therapeutic agents
GB9505492D0 (en) Therapeutic agents
HU9601176D0 (en) Adhesion-receptor antagonists
EP0832125A4 (en) Human g-protein receptor hgber32
GB9507291D0 (en) Therapeutic agents
EP0853629A4 (en) Hepadnavirus receptor
GB9519563D0 (en) Therapeutic agents
EP0809648A4 (en) Neuropeptide y receptor
GB9507348D0 (en) Therapeutic agents
GB9517098D0 (en) Receptor
GB9500580D0 (en) Therapeutic agents
EP0832122A4 (en) Human g-protein receptor hpraj70
GB9501865D0 (en) Therapeutic agents
GB9513467D0 (en) Therapeutic agents
AU6035398A (en) Human c5a-like receptor
EP0835264A4 (en) Human g-protein receptor hcegh45
EP0792282A4 (en) Human endothelin-bombesin receptor
EP0812329A4 (en) Human g-protein coupled receptor
EP0832124A4 (en) Human amine receptor
ZA953792B (en) Human neuropeptide receptor
GB9519558D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19971205

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20030715

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20091201